Latest Lead News

DTI Group Limited has inked a global Master Framework Agreement with Siemens Mobility GmbH, streamlining worldwide purchasing and opening doors to new rail and bus sector projects. Despite a modest cash balance, DTI is advancing its flagship software, positioning itself for growth.

Battery Age Minerals has executed a Farm-In Agreement to acquire up to 100% ownership of the El Aguila gold and silver project in Argentina’s prolific Santa Cruz province, unveiling promising high-grade mineralisation and significant exploration upside.

Electro Optic Systems has completed the sale of EM Solutions for $158.6 million, exceeding initial valuations, and fully repaid its debt to Washington H. Soul Pattinson, leaving the company debt-free with a strong cash position.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.

Rubix Resources has identified significant untested chargeability anomalies at its Paperbark project, submitting applications for co-funding to drill these promising targets while progressing exploration across its diversified portfolio.

Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.

Lode Resources has completed the acquisition of the Montezuma Antimony Project in Tasmania, delivering high-grade drill results that bolster its strategy to become a leading Australian antimony producer amid global supply shortages.

Tolu Minerals reports significant progress in recommencing production and expanding resources at its Tolukuma mine, underpinned by strategic hires and advanced geophysical surveys.

Kinetiko Energy reports mixed results from its five-well gas production test program, with the first well underperforming but the company maintaining optimism for the remaining wells and a strong financial footing.

Thunderbird Resources has significantly bolstered its portfolio with the acquisition of the Rockvale and Kookabookra antimony-gold projects in New South Wales, alongside promising uranium exploration results in Canada. These developments position the company for a dynamic 2025 exploration season.

Chimeric Therapeutics has dosed the first three patients in its Phase 1/2 CHM CDH17 CAR-T trial targeting gastrointestinal cancers, alongside advancing its AML and NK cell therapy programs. The company also secured $5 million in funding and appointed Dr Rebecca McQualter as CEO.

Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.